Companies: 10,795·Total market cap: $144.5T
Johnson & Johnson

Johnson & Johnson

JNJNYSEHealthcare● Active
$232.77
+$4.60(+2.02%)
Market Cap$560.3B
P/E Ratio
52W High$251.71
52W Low$149.04

Johnson & Johnson (JNJ) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

jnj · stock forecast · 40 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 40 Wall Street analysts in the past 3 months

SellBuy

Buy

40 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
21
Hold
16
Sell
3
Strong Sell
0
Total: 40 · Buy rate: 52.5%

12-Month Price Target

High

$283

Consensus

$251

+7.7% upside

Low

$208

Median: $252.5 · Last Close: $232.77

The Johnson & Johnson (JNJ) analyst consensus is Buy, based on ratings from 40 Wall Street analysts over the past 3 months. The average 12-month JNJ price target is $250.58, representing +7.7% upside from the current price of $232.77.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $251 (7.7%)

Consensus Target

$250.58

7.7% upside

High Target

$283

21.6%

Low Target

$208

-10.6%

Current Price

$232.77

as of today

Based on analyst price targets, the JNJ stock price prediction for the next 12 months ranges from $208 to $283. The consensus JNJ price forecast of $250.58 implies 7.7% upside from the current price of $232.77.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$231.250.65%

1-day model range: $230.74–$231.77. Peak: $231.77 (-0.65%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$277+18.9%
2028$311+33.6%
2029$336+44.2%
2030$353+51.7%
2031+56.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%7%14%
11Buy
1Neutral
2Sell
RSI (14)59.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · JNJ · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$226.12BUY
MA 10$228.25BUY
MA 20$227.87BUY
MA 50$231.45BUY
MA 100$233.71SELL
MA 200$213.13BUY
Current $JNJ · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$228.27BUY
EMA 10$227.91BUY
EMA 20$228.19BUY
EMA 50$229.92BUY
EMA 100$226.99BUY
EMA 200$214.33BUY
Current $JNJ · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Leerink Partners2026-05-13
Upgrade ↑
Market PerformOutperform
Barclays2026-04-15
Maintains
Equal WeightEqual Weight
Wells Fargo2026-04-15
Maintains
OverweightOverweight
Stifel2026-04-15
Maintains
HoldHold
Morgan Stanley2026-04-10
Maintains
OverweightOverweight
RBC Capital2026-03-30
Maintains
OutperformOutperform
Barclays2026-03-19
Maintains
Equal WeightEqual Weight
HSBC2026-03-17
Maintains
BuyBuy
Citigroup2026-03-11
Maintains
BuyBuy
JP Morgan2026-03-05
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Johnson & Johnson (JNJ) stock. Of the recent 376 rating actions, 27 were upgrades and 24 were downgrades. 40 analysts currently cover JNJ.

Analyst Recommendation Trends

Buy ratings413
Hold ratings404
Sell ratings00

JNJ analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$100.9B

↓ 12.2% YoY

Revenue Next Year

$107.7B

↑ 6.8% YoY

EPS This Year

$11.58

EPS Next Year

$12.77

↑ 10.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast JNJ EPS of $11.58 for the current fiscal year, based on estimates from 13 analysts. The JNJ revenue forecast is $100.9B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The JNJ stock forecast is supported by two independent data sources: analyst consensus ratings from 40 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus JNJ price target is $250.58 (+7.7% upside), with an analyst consensus of Buy.

The JNJ short-term stock prediction for tomorrow is $231.25 (-0.65%). The JNJ stock price prediction for 2027 estimates an average of $277. The JNJ stock prediction for 2030 projects a range of $345–$362.

Johnson & Johnson trades on NYSE under the ticker JNJ. The JNJ stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

JNJ forecast · 8 questions

According to 40 Wall Street analysts, the average 12-month JNJ price target is $250.58, with a high forecast of $283.00 and a low of $208.00. The median price target is shown in the chart above when available. This implies +7.7% potential upside from the current price of $232.77.

JNJ price targetWhat is JNJ price targetJNJ analyst price targetJNJ 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.